Parkinson's Disease Flashcards

1
Q

What are the different types of PD

A
  • Idiopathic PD (most often)
  • Parkinson’s plus (less data on what agents work eg. levodopa):
    Multiple system atrophy (aka Shy-Drager syndrome)
    Progressive supranuclear palsy
    Corticobasal degeneration
    Lewy body disease
  • Parkinsonism (manifestation of the syndrome? Different MOA from idiopathic PD)
    Drug-induced, toxin-induced
    Vascular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 characteristic features of PD

A

Tremor - resting tremor (not doing anything)
Rigidity - muscular rigidity (cogwheel hypertonic? Increase contraction)
Akinesia - slowness & poverty of movement
Postural instability (gait)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How to diagnose PD?

A
  • 2 of the 3 cardinal signs must be present
  • Tremor: resting tremor (disappears with movement), increases with stress
  • Rigidity: “ratchet”- like stiffness (cogwheel rigidity); also lead pipe rigidity
  • Akinesia/bradykinesia: subjective sense of weakness, loss of dexterity, difficulty using kitchen tools, loss of facial expression, reduced blinking, difficulty getting out of bed/chair, difficulty turning while walking.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What features appear at initial presentation of idiopathic PD

A
  • Asymmetric
  • Positive response to levodopa or apomorphine
  • Postural Instability (& falls)- not present at diagnosis
  • Less rapid progression (rapid= H&Y 3 in 3 years)
  • Autonomic dysfunction– not present
  • Neuroimaging- ??
  • Impaired olfaction (?)
  • Honeymoon period of 1st 3 yrs whr even w diagnosis, dont need/minimal pharmacological intervention, pt still can lead normal life.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens to pt as PD progresses

A
  • Unable to perform basic ADLs (or to perform them safely):
    Mobility (walking, using stairs) - increase falls
    Feeding self
    Grooming, personal hygiene
    Toileting
    Showering/bathing
    Continence (bowel and bladder)
  • Choking (swallowing problems)
  • Pneumonia
  • Falls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the greatest burden of PD

A

Costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the features of early/young onset PD <40y/o

A
  • Slower disease progression
  • Features:
    < Cognitive decline
    Earlier motor complications
    Dystonia is common initial presentation vs falls & freezing in late-onset
  • Dopamine agonists used in preference to levodopa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is goals of tx for PD

A

No cure
Manage symtpoms
Maintain function and autonomy
No treatment for PD has ever been shown to be “neuroprotective”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the classes of drugs for PD Tx

A

Increase central dopamine, dopaminergic transmission:
- Levodopa + DCI
- Dopamine agonists
- MAO B inhibitors
- COMT inhibitors

Correct imbalance in other pathways
- Anticholinergics
- NMDA antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is nonpharm tx for PD

A

PT (help them move):
- Stretching, transfers, posture
- Walking (draw a line or shine a light then they walk towards it to “unfreeze” them)

OT:
- Mobility aids, home &
- Workplace safety
- Speech & swallowing (how big can they swallow? Can crush?)
- Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which drug is most effective for treating PD smx

A

Levodopa

Esp bradykinesia & rigidity
Less effective for speech, postural reflex & gait disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Can dopamine be used as a treatment? Why?

A

No, it does not cross the blood-brain- barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SE of levodopa

A

N/V (take with meals), orthostatic hypotn, drowsiness, sudden sleep onset, hallucinations, psychosis, dsykinesias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does levodopa work?

A

Peripheral conversion of levodopa to dopamine: Is catalysed by DOPA decarboxylase, MAO, COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why are DCI (benserazide, carbidopa) added to levodopa?

A

Increased bioavailability, prevents break down on levodopa outside of BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of meals affect absorption of levodopa

A

Absorption ↓ with high fat or high protein meals.

Counselling: space apart from heavy meal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Does DCI cross BBB?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is dose of levodopa

A

75-100mg daily

DCI : levodopa
either 1:4 or 1:10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the “On-off” phenomenon?

A
  • ON = response to levodopa (helps gain mobility -> so less adherence issues),
  • OFF = no response to levodopa
  • Unpredictable, not related to dose/dosing interval (cant tweak dosing regimen)
  • “throwing a light switch”
  • Mechanism unclear
  • Difficult to control with meds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the “wearing off” complication and how to manage it

A
  • Effect of levodopa wanes before the end of the dosing interval
  • Shortened “ON” time
  • Associated with disease progression
  • Management:
    Modify times of administration, and/or
    Replace with modified-release preparations at the appropriate time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is dyskinesias motor complications and how to manage?

A
  • Can be unpredictable like “on-off” even if you flatten the peak dose so add amantadine
  • Involuntary, uncontrollable
  • Twitching, jerking
  • Peak dose dyskinesia
  • Dystonia
  • Management : add amantadine; replace specific doses with modified-release levodopa
22
Q

How to dose adjustment when switching btw immediate release and controlled release forms?

A

IR to CR : generally ↑ dose needed (~25%,-50%)
CR to IR : generally ↓ dose needed

23
Q

Sustained released forms are useful for __

A

↓ stiffness upon waking

24
Q

Examples of sustained released forms

A

Sinemet SR
Madopar HBS

25
What DDI with levodopa?
Pyridoxine: - Cofactor for dopa decarboxylase - Generally not a problem if levodopa is administered with a DCI but do be aware of the possibility of interactions with High dose B6 for haematological problems or in high potency vit B complex tabs Iron: Affects absorption of levodopa -> space out administration Protein: Affects absorption of levodopa -> space out administration Dopamine antagonists: - Metoclopramide, prochlorperazine (N&V) - Antiemetic of choice in PD = domperidone (for GI motility) - 1st gen antipsychotics - if possible, avoid unless thr is indication then R vs B, which is more pressing issue to tackle - Risperidone
26
Examples of dopamine agonists
Cabergoline Ropinirole Pramipexole
27
Peripheral SE of dopamine agonists
N&V Orthostatic hypotension Leg edema
28
Central SE of dopamine agonists
- Hallucinations (usually visual > auditory) - Somnolence, day-time sleepiness (similar to levo due to similar MOA) - Compulsive behaviours: Gambling, shopping, eating, hypersexuality Act on reward system Caregivers need to watch out! Then stop drug
29
CV SE of dopamine agonists
Fibrosis: - Pulmonary, pericardiac, retro-peritoneal - May be partially reversible upon withdrawal - Lower risk with non-ergot agents Valvular heart disease: Incidence appears to be greater with ergot-derived agents (∴not used often now)
30
Dopamine agonists vs levodopa place in therapy?
- < motor complications than levodopa but… - > hallucinations, sleep disturbances, leg oedema, orthostatic hypotension - No clinically significant differences in efficacy between agents - Frequently preferred over levodopa in younger patients: to maximise treatment options and delay the onset of levodopa- induced motor complications (unless rly bothered by tx)
31
Dopamine agonists place in therapy?
- Monotherapy In Young-onset PD - Adjunct to levodopa in moderate/severePD - Management Of Motor Complications Caused By Levodopa -> can give lower dose - Neuroprotection, disease modification??
32
Which PD drug is available as transdermal patch?
Rotigotine
33
Examples of MAO-B inhibitors for PD
Selegiline, rasagiline
34
What is MAO-Bi place in therapy?
Effective as monotherapy in early stages
35
Dose of selegiline
5mg OM to BD (second dose in afternoon)
36
Dose of rasagiline
0.5 to 2mg once daily
37
DDI with MAOBi
- SSRIs, SNRIs, TCAs: Wash out periods recommended - Pethidine, tramadol, - Linezolid - Dextromethorphan - Dopamine - Sympathomimetics : nasal decongest eg. pseudoephedrine, phenylephrine - Another MAOi
38
Food interactions with MAOBi
tyramine, cheeses, meat, soy sauce
39
Among levodopa, dopamine agonists and MAOBi, which has more improvements in motor smx and more motor complications?
Levodopa
40
Example of Catechol-O-Methyl Transferase Inhibitors (COMT-i)
Entacapone
41
DDI with entacapone
- Iron, calcium, - Avoid concurrent nonselective MAOi (but safe with MAO- Bi, caution with selective MAO-Ai) - any catecholamine drug - Enhance anticoagulant effect of warfarin
42
SE of entacapone
Diarrhoea, urine discolouration (orange), dyskinesia upon initiation, orthostatic hypotn, N/V
43
Which drug must Entacapone be taken with
Levodopa
44
Anticholinergics place in therapy
Limited use, primarily used to control temors
45
Example of anticholinergic used in PD
Benzhexol
46
NMDA antagonists place in therapy
Adjunctive, manage levodopa-induced dyskinesia
47
SE of NMDA antagonist
Nausea, light headedness, insomnia, confusion, hallucinations, livedo reticularis
48
What complementary medicines have shown some effect for PD
Co-enzyme Q10 Creatine Vit E Gluthathione Riboflavin Lipoic acid Acetyl carnitine Curcumin
49
How to differentiate drug induced parkinsonism vs PD
Smx tend to occur bilaterally in DIP Withdrawal of the drug usually leads to improvement in 80% of smx in 8wks
50
Examples of drugs that can induce parkinsonism
High risk: Typical antipsychotics Atypical antipsychotics a-methyldopa Cinnarizine Intermediate risk: Valproate, phenytoin, levetiracetam Prochlorperazine, metoclopramide Diltiazem, verapamil Lithium